Targeted cluster ablation of non-CTI-dependent atrial arrhythmias in congenital heart disease using ultrahigh-definition mapping.
atrial arrhythmias
catheter ablation
congenital heart disease
ultrahigh-density mapping
Journal
Journal of cardiovascular electrophysiology
ISSN: 1540-8167
Titre abrégé: J Cardiovasc Electrophysiol
Pays: United States
ID NLM: 9010756
Informations de publication
Date de publication:
05 2022
05 2022
Historique:
revised:
16
02
2022
received:
30
10
2021
accepted:
20
02
2022
pubmed:
1
3
2022
medline:
21
4
2022
entrez:
28
2
2022
Statut:
ppublish
Résumé
Ablation of atrial arrhythmias in patients with congenital heart disease (CHD) has markedly improved with advanced mapping systems. However, recurrence rates remain high. The linear ablation strategy is not uncommonly practiced necessitating prolonged ablation times. We report the outcomes of adopting a strategy of minimal, cluster delivery of radiofrequency (RF) energy at critical substrates identified by ultrahigh-definition mapping for atrial arrhythmias in patients with CHD. Non-cavotricuspid isthmus (non-CTI) atrial tachycardias were ablated with a targeted ablation cluster technique (TACT) using an ultrahigh-density mapping system combined with multielectrode monitoring and endpoint determination in preference to linear ablation. The arrhythmia substrates, RF times, and acute- and medium-term success rates were studied. Fifty-eight tachycardias were mapped and ablated in 42 procedures: 34 non-CTIs and 24 CTIs. A targeted ablation cluster was performed for non-CTI tachycardias, with a median ablation time of 3.1 min. In 53% of non-CTI tachycardias, arrhythmia termination was achieved with ≤2 RF applications. After a mean follow-up of 23.6 months, 27 (80%) patients were free of recurrent atrial arrhythmias. One of 34 targeted non-CTI tachycardia recurred, with a final success rate of 91%. Linear ablation was performed for CTI flutters with a median ablation time of 6.8 min (vs. non-CTIs, p = .006). Three of 21 tachycardias recurred due to reconnection of the ablation line but the final success rate was 100%. The TACT approach for non-CTI atrial arrhythmias in congenital patients as guided by the ultrahigh-density mapping is an effective method with short ablation times and excellent medium-term outcomes.
Sections du résumé
BACKGROUND
Ablation of atrial arrhythmias in patients with congenital heart disease (CHD) has markedly improved with advanced mapping systems. However, recurrence rates remain high. The linear ablation strategy is not uncommonly practiced necessitating prolonged ablation times. We report the outcomes of adopting a strategy of minimal, cluster delivery of radiofrequency (RF) energy at critical substrates identified by ultrahigh-definition mapping for atrial arrhythmias in patients with CHD.
METHODS
Non-cavotricuspid isthmus (non-CTI) atrial tachycardias were ablated with a targeted ablation cluster technique (TACT) using an ultrahigh-density mapping system combined with multielectrode monitoring and endpoint determination in preference to linear ablation. The arrhythmia substrates, RF times, and acute- and medium-term success rates were studied.
RESULTS
Fifty-eight tachycardias were mapped and ablated in 42 procedures: 34 non-CTIs and 24 CTIs. A targeted ablation cluster was performed for non-CTI tachycardias, with a median ablation time of 3.1 min. In 53% of non-CTI tachycardias, arrhythmia termination was achieved with ≤2 RF applications. After a mean follow-up of 23.6 months, 27 (80%) patients were free of recurrent atrial arrhythmias. One of 34 targeted non-CTI tachycardia recurred, with a final success rate of 91%. Linear ablation was performed for CTI flutters with a median ablation time of 6.8 min (vs. non-CTIs, p = .006). Three of 21 tachycardias recurred due to reconnection of the ablation line but the final success rate was 100%.
CONCLUSIONS
The TACT approach for non-CTI atrial arrhythmias in congenital patients as guided by the ultrahigh-density mapping is an effective method with short ablation times and excellent medium-term outcomes.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
932-942Informations de copyright
© 2022 Wiley Periodicals LLC.
Références
Dorostkar PC, Cheng J, Scheinman MM. Electroanatomical mapping and ablation of the substrate supporting intraatrial reentrant tachycardia after palliation for complex congenital heart disease. Pacing Clin Electrophysiol. 1998;21(9):1810-1819.
Brouwer C, Hazekamp MG, Zeppenfeld K. Anatomical substrates and ablation of reentrant atrial and ventricular tachycardias in repaired congenital heart disease. Arrhythm Electrophysiol Rev. 2016;5(2):150-160.
Khairy P, Van Hare GF, Balaji S, et al. PACES/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Heart Rhythm. 2014;11(10):e102-e165.
Van Hare GF. Challenges in ablation of complex congenital heart disease. Card Electrophysiol Clin. 2019;11(4):711-718.
Chiu SN, Lin JL, Tsai CT, et al. Radiofrequency catheter ablation of atrial tachyarrhythmias in adults with repaired congenital heart disease: constraints from multiple and new arrhythmic foci. Acta Cardiol Sin. 2013;29(4):347-356.
Martin CA, Yue A, Martin R, et al. Ultra-High-density activation mapping to aid isthmus identification of atrial tachycardias in congenital heart disease. J Am Coll Cardiol EP. 2019;5(12):1459-1472.
Mantziari L, Butcher C, Shi R, et al. Characterization of the mechanism and substrate of atrial tachycardia using ultra-high-density mapping in adults with congenital heart disease: impact on clinical outcomes. J Am Heart Assoc. 2019;8(4):e010535.
Ernst S, Cazzoli I, Guarguagli S. An initial experience of high-density mapping-guided ablation in a cohort of patients with adult congenital heart disease. Europace. 2019;21(suppl_1):i43-i53.
Grubb CS, Lewis M, Whang W, et al. Catheter ablation for atrial tachycardia in adults with congenital heart disease: electrophysiological predictors of acute procedural success and post-procedure atrial tachycardia recurrence. J Am Coll Cardiol EP. 2019;5(4):438-447.
Roca-Luque I, Rivas-Gándara N, Dos-Subirà L, et al. Predictors of acute failure of ablation of intra-atrial reentrant tachycardia in patients with congenital heart disease: cardiac disease, atypical flutter and previous atrial fibrillation. J Am Heart Assoc. 2018;7(7):e008063.
Krause U, Müller MJ, Stellmacher C, Backhoff D, Schneider H, Paul T. High density mapping and catheter ablation of atrial tachycardias in adults with congenital heart disease. Clin Res Cardiol. 2020;109(8):999-1007.
Derval N, Takigawa M, Frontera A, et al. Characterization of complex atrial tachycardia in patients with previous atrial interventions using high-resolution mapping. J Am Coll Cardiol EP. 2020;6(7):815-826.
Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart. Association task force on practice guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease). Developed in collaboration with the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;52:e143-e263.
Saoudi N, Cosío F, Waldo A, et al. A classification of atrial flutter and regular atrial tachycardia according to electrophysiological mechanisms and anatomical bases; a statement from a joint expert group from the working group of arrhythmias of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J. 2001;22(14):1162-1182.
Klehs S, Schneider HE, Backhoff D, Paul T, Krause U. Radiofrequency catheter ablation of atrial tachycardias in congenital heart disease: results with special reference to complexity of underlying anatomy. Circ Arrhythm Electrophysiol. 2017;10(12):e005451.
Waldmann V, Amet D, Zhao A, et al. Catheter ablation of intra-atrial reentrant/focal atrial tachycardia in adult congenital heart disease: value of final programmed atrial stimulation. Heart Rhythm. 2020;17(11):1953-1959.
Katritsis G, Luther V, Cortez-Dias N, et al. Electroanatomic characterization and ablation of scar-related isthmus sites supporting perimitral flutter. J Am Coll Cardiol EP. 2021;7(5):578-590.
Brouwer C, Hebe J, Lukac P, et al. Contemporary patients with congenital heart disease: uniform atrial tachycardia substrates allow for clear ablation endpoints with improved long-term outcome. Circ Arrhythm Electrophysiol. 2021;14(9):e009695.
Barbhaiya CR, Kumar S, Ng J, et al. Overdrive pacing from downstream sites on multielectrode catheters to rapidly detect fusion and to diagnose macroreentrant atrial arrhythmias. Circulation. 2014;129(24):2503-2510.
Maury P, Champ-Rigot L, Rollin A, et al. Comparison between novel and standard high-density 3D electro-anatomical mapping systems for ablation of atrial tachycardia. Heart Vessels. 2019;34(5):801-808.
Moore JP, Buch E, Gallotti RG, Shannon KM. Ultra high-density mapping supplemented with global chamber activation identifies non cavotricuspid-dependent intra-atrial re-entry conduction isthmuses in adult congenital heart disease. J Cardiovasc Electrophysiol. 2019;30(12):2797-2805.
Alken FA, Klatt N, Muenkler P, et al. Advanced mapping strategies for ablation therapy in adults with congenital heart disease. Cardiovasc Diagn Ther. 2019;9(suppl 2):S247-S263.